Vir Biotechnology (VIR) FCF Margin (2018 - 2026)
Vir Biotechnology (VIR) reported FCF Margin of 457848.28% for Q1 2026, down 45521816.0% on a YoY basis from N/an in Q1 2025, and down 1118506.58% sequentially from 40.93% in Q4 2025.
Vir Biotechnology (VIR) FCF Margin (2018 - 2026) Analysis & Trends
Vir Biotechnology (VIR) has 9 years of FCF Margin data on file, last reported at 457848.28% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin fell 45521816.0% year-over-year to 457848.28%; the trailing twelve-month figure through Mar 2026 stood at 685.92% (up 133764.0% YoY), and the FY2025 full-year result was 578.52%, up 3283.0% from the prior year.
- FCF Margin retreated to 457848.28% in Q1 2026, from 40.93% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 2312.48% in Q2 2022 to a low of 457848.28% in Q1 2026.
- A 5-year average of 33316.42% and a median of 724.34% in 2024 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin jumped 794723 bps in 2024 and tumbled 45521816 bps in 2026, its largest moves.
- Tracing VIR's FCF Margin over 5 years: stood at 45.64% in 2022, then plunged by 1529 bps to 652.06% in 2023, then dropped by 11 bps to 724.34% in 2024, then soared by 94 bps to 40.93% in 2025, then sank by 1118507 bps to 457848.28% in 2026.
- Business Quant data shows VIR's FCF Margin at 457848.28% in Q1 2026, 40.93% in Q4 2025, and 69952.92% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Vir Biotechnology | 1.38 Bn | 1.38 Bn | - | -457,848.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -457,848.28% |
| Dec 31, 2025 | -40.93% |
| Sep 30, 2025 | -69,952.92% |
| Jun 30, 2025 | -10,111.78% |
| Mar 31, 2025 | -2,630.11% |
| Dec 31, 2024 | -724.34% |
| Sep 30, 2024 | -7,321.34% |
| Jun 30, 2024 | -2,553.27% |
| Mar 31, 2024 | -215.21% |
| Dec 31, 2023 | -652.06% |
| Sep 30, 2023 | -6,045.59% |
| Jun 30, 2023 | -10,500.50% |
| Mar 31, 2023 | -210.70% |
| Dec 31, 2022 | 45.64% |
| Sep 30, 2022 | 26.41% |
| Jun 30, 2022 | 2,312.48% |
| Mar 31, 2022 | 43.35% |
| Dec 31, 2021 | -1.22% |
| Sep 30, 2021 | -103.77% |
| Jun 30, 2021 | 81.97% |